United States Skincare Compliance Guide

Last reviewed: August 2026. This guide is for skincare products intended to be sold in the United States as cosmetics. It is a practical planning resource, not legal advice; confirm product-specific requirements before launch.

Understand FDA and U.S. cosmetic regulation

The U.S. Food and Drug Administration (FDA) regulates cosmetics under the Federal Food, Drug, and Cosmetic Act, the Fair Packaging and Labeling Act, and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). MoCRA expanded FDA’s authority over cosmetic safety, facility registration and product listing.

A key distinction: FDA does not generally pre-approve cosmetic products or cosmetic labels before they enter the market. Facility registration and product listing are compliance obligations where applicable; they are not FDA product approval, certification or a marketing endorsement.

Companies that manufacture or market cosmetics remain responsible for ensuring their products are safe and properly labeled.

Confirm that the product can follow the cosmetic route

For a skincare product to be regulated as a cosmetic, its intended use and claims should be limited to cleansing, beautifying, promoting attractiveness or altering appearance. The same formula can be treated differently when its claims change.

Claims that need early review

• Claims to treat or prevent disease, such as acne treatment or eczema relief.
• Claims that affect the structure or function of the body or skin.
• Product categories with a potential drug route, including sunscreen and certain anti-acne products.
• Any claim used on packaging, websites, social media, retailer pages or sales materials.

If the product may be a drug or a drug/cosmetic, do not rely on this cosmetic-market-entry workflow alone. Obtain a product-specific regulatory assessment before proceeding.

U.S. market-entry overview

1. Classify the Product
2. Confirm Parties & Site
3. Prepare Technical File
4. Review Label & Claims
5. Complete FDA Submissions
6. Maintain After Launch

1. Classify the product. Review the product format, intended use and proposed U.S. claims.
2. Confirm the parties. Identify the responsible person, manufacturing site and submission roles.
3. Prepare the technical file. Organize formula, safety, testing, manufacturing and traceability support.
4. Review the U.S. label. Align product identity, net contents, ingredient declaration, business information, warnings and import information.
5. Complete applicable FDA submissions. Assess facility registration and product listing obligations, including any exemption analysis.
6. Maintain compliance after launch. Control complaints, serious adverse events, changes and record retention.

What the factory needs and does

The factory provides the manufacturing and technical foundation for the market file. Its role is not limited to supplying a formula: it must provide reliable site, quality and product information to the brand or responsible person.

Factory readiness information

• Legal entity and manufacturing-site details, including the FDA Establishment Identifier (FEI) where required for facility registration.
• Facility-registration status and an assessment of whether the facility and product are subject to, or exempt from, MoCRA registration and listing requirements.
• Quality-system and GMP-related documentation, manufacturing procedures, batch records, traceability and change-control procedures.
• Complete formula, INCI information, raw-material specifications and relevant supplier documentation.
• Available safety, stability, microbiological, packaging-compatibility and efficacy-support records relevant to the finished product.

Factory support workflow

1. Confirm the product format, manufacturing site and U.S. market intention with the brand.
2. Provide the current formula, ingredient data and applicable technical-support documents.
3. Support safety substantiation, label review and product-listing data preparation.
4. Maintain batch traceability, controlled changes and documentation updates after launch.

ISO 22716, GMPC certificates or customer audits can be important commercial-quality evidence, but they are not an FDA product approval. Separate regulatory obligations from customer or retailer qualification standards.

What the brand needs and does

The brand owns the market-facing decisions. It must ensure that the final product positioning, label, claims and post-market arrangements match the route selected for the United States.

Brand readiness information

• Defined target channel, intended use, product positioning and final claims.
• An identified responsible person: the manufacturer, packer or distributor whose name appears on the label.
• Approved U.S. label artwork, product-page copy, advertising claims and any required warnings.
• A clear process for product listing, updates, complaint intake, serious adverse-event escalation and change communication.
• Commercial records needed to support the final version of the product placed on the U.S. market.

Brand workflow

1. Set the U.S. product concept and claims boundaries before finalizing formula or packaging.
2. Confirm the responsible person and align submission responsibilities with the factory.
3. Review and approve the formula support file, final label and claim matrix.
4. Submit or coordinate the applicable product listing and maintain product information as required.
5. Operate the post-market process for consumer complaints, serious adverse events and material product changes.

FDA facility registration and product listing

Under MoCRA, manufacturers and processors that are required to register must register their facilities with FDA and renew registration every two years. A responsible person must list each marketed cosmetic product with FDA, including its ingredients, and provide updates annually. Certain small businesses may be exempt, but exemptions are not universal and do not apply to every product type.

Practical submission path

1. Check whether the manufacturing facility is required to register and whether any exemption applies.
2. Confirm the facility’s FEI and current registration information.
3. Identify the responsible person named on the product label.
4. Prepare the product name, category, ingredient and manufacturing-site information required for the listing.
5. Use FDA’s current submission route, including Cosmetics Direct where appropriate.
6. Set ownership for biennial facility renewal, annual listing updates and changes to the product or manufacturing information.

Label, claims and document checklist

U.S. label review

• Product identity statement and accurate net quantity of contents.
• Name and place of business for the manufacturer, packer or distributor, with qualifying wording where needed.
• Ingredient declaration for retail consumer products, generally in descending order of predominance.
• Required warnings, directions or material facts for the product type.
• English-language requirements and country-of-origin marking for imported products.

Core market file

• Final formula and ingredient/INCI declaration
• Raw-material specifications and relevant supplier documentation
• Safety rationale and supporting test records
• Stability, microbiological and packaging-compatibility evidence, as relevant
• Final U.S. label artwork and claims matrix
• Manufacturing, batch-traceability and change-control records
• Facility registration and product-listing information, where required

Maintain compliance after launch

Compliance continues after the product is sold. Keep safety-support records current, assess formula, label and manufacturing changes before implementation, retain complaint records and maintain an escalation path for serious adverse events. FDA registration and listing do not remove the responsible person’s or manufacturer’s obligation to ensure product safety and proper labeling.

Official FDA resources

• Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
• Registration & Listing of Cosmetic Product Facilities and Products
• Summary of Cosmetics Labeling Requirements
• Cosmetics Labeling Regulations
• Product Testing of Cosmetics
• FDA Direct / Cosmetics Direct